Shrimp Biocontrol Welfare: Probiotic and Immune Enhancement Programs

Biocontrol approaches using probiotics and immune enhancers reduce disease burden in farmed shrimp while avoiding the welfare harms of antibiotic treatment and prophylactic chemical use.

Key Facts

Probiotics including Bacillus subtilis and Lactobacillus species colonize shrimp gut and outcompete pathogens
Beta-glucan dietary supplements stimulate shrimp non-specific immune function, reducing Vibrio susceptibility
Phage therapy — using bacteriophages to target specific bacterial pathogens — is under development for shrimp disease
Biocontrol approaches can reduce antibiotic use by 60-80% while maintaining equivalent or better disease outcomes
Probiotic efficacy varies significantly by species, strain, dose, and water quality — product selection requires evidence review
International antibiotic resistance monitoring programs increasingly include aquaculture shrimp as surveillance targets

Welfare Considerations

Shrimp biocontrol welfare operates at the intersection of disease prevention and antibiotic resistance stewardship. Prophylactic antibiotic use in shrimp farming causes welfare harms through antibiotic resistance selection that limits treatment options when genuine disease occurs. Biocontrol approaches that prevent disease without promoting resistance protect both individual shrimp welfare and broader public health welfare. The regulatory environment is increasingly favorable — several major importing countries have banned antibiotic residues in shrimp, creating market incentives for biocontrol investment.

What You Can Do

Purchase shrimp products certified by programs prohibiting prophylactic antibiotic use
Support research into shrimp-specific probiotic strains with documented efficacy and welfare benefits
Advocate for antibiotic-free certification requirements in shrimp procurement by major retailers and foodservice
Contact shrimp retailers asking about their supplier antibiotic use policies and biocontrol adoption